Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major ...

Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly ...

Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, ...

11 January 2022 Alexion, AstraZeneca’s rare disease group, has entered into an exclusive licensing agreement with Neurimmune ...

Appeals board overturns previous decision and revokes patent on treatment worth $2bn in 2024 | Teva and Generics UK successful in arguing lack of inventive step. Already registered? If you don't have ...

David Gindler of Orrick discusses the US Supreme Court’s ruling in Amgen v. Sanofi and what it means for ongoing Section 112 litigation. The session considers how the decision has been applied – and ...

22 May 2025 AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision ...

4 February 2025 Federal Circuit upholds preliminary injunctions blocking highly similar versions of Eylea | Samsung Biopeis ...

Despite efforts to harmonise, the Unified Patent Court’s local divisions and Court of Appeal have signalled a divergence over ...

Regeneron files motion to disqualify firm from patent and antitrust dispute | Motion cites conflict of interest due to ...

Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.